A Phase III, Multi-centre, Randomized Trial to Compare Rivaroxaban With Placebo for the Treatment of Symptomatic Leg Superficial Vein Thrombosis
Phase of Trial: Phase III
Latest Information Update: 09 Dec 2016
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Venous thrombosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms RASET
- 06 Dec 2016 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.
- 06 Dec 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 20 Nov 2014 Status changed from not yet recruiting to recruiting, according to ClnicalTrials.gov